Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

(2011) Sven Wach et al.   INTERNATIONAL JOURNAL OF CANCER

Development of microRNA-145 for therapeutic application in breast cancer

(2011) Seok-Jun Kim et al.   JOURNAL OF CONTROLLED RELEASE

MicroRNA-100 Expression is Independently Related to Biochemical Recurrence of Prostate Cancer

(2011) Katia R.M. Leite et al.   JOURNAL OF UROLOGY

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections

(2011) Sergio Marchini et al.   LANCET ONCOLOGY

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

(2011) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression

(2011) Ling-Zhi Liu et al.   PLoS One

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

(2011) Fulya Yaman Agaoglu et al.   TUMOR BIOLOGY

The functional significance of microRNA-145 in prostate cancer

(2010) M S Zaman et al.   BRITISH JOURNAL OF CANCER

MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer

(2010) Y. Chen et al.   Cancer Prevention Research

Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients

(2010) Felix Moltzahn et al.   CANCER RESEARCH

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

(2010) Hai-Liang Zhang et al.   PROSTATE

MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

(2009) J. Wang et al.   Cancer Prevention Research

Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer

(2009) L. Wang et al.   CANCER RESEARCH

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines

(2009) T. Sun et al.   CANCER RESEARCH

MicroRNAs and prostate cancer

(2009) Valeria Coppola et al.   ENDOCRINE-RELATED CANCER

Head-to-Head Comparison of the Three Most Commonly Used Preoperative Models for Prediction of Biochemical Recurrence After Radical Prostatectomy

(2009) Giovanni Lughezzani et al.   EUROPEAN UROLOGY

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer

(2009) Zhaohui Huang et al.   INTERNATIONAL JOURNAL OF CANCER

Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis

(2009) Matthew R. Cooperberg et al.   JNCI-Journal of the National Cancer Institute

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Serum MicroRNAs Are Promising Novel Biomarkers

(2008) Shlomit Gilad et al.   PLoS One

The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice

(2008) Neri Mercatelli et al.   PLoS One

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA